Please use this identifier to cite or link to this item:
|Title:||Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells|
|Author:||Guimarães, Douglas M.|
Almeida, Luciana O.
Martins, Manoela D.
Warner, Kristy A.
Silva, Alan R. S.
Vargas, Pablo A.
Nunes, Fabio D.
Squarize, Cristiane H.
Nör, Jacques E.
Castilho, Rogerio M.
|Abstract:||Mucoepidermoid carcinoma (MEC) is the most common malignancy of salivary glands. The response of MEC to chemotherapy is unpredictable, and recent advances in cancer biology suggest the involvement of cancer stem cells (CSCs) in tumor progression and chemoresistance and radioresistance phenotype. We found that histone acetyltransferase inhibitors (HDACi) were capable of disrupting CSCs in MEC. Furthermore, administration of HDACi prior to Cisplatin (two-hit approach) disrupts CSCs and sensitizes tumor cells to Cisplatin. Our findings corroborate to emerging evidence that CSCs play a key role in tumor resistance to chemotherapy, and highlights a pharmacological two-hit approach that disrupts tumor resistance to conventional therapy.|
|Subject:||Neoplasias das glândulas salivares|
|Appears in Collections:||FOP - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.